DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more



Effect of Tamsulosin vs Prazosin in Treatment of Female Voiding Dysfunction

Information source: Tabriz University
Information obtained from ClinicalTrials.gov on June 20, 2008
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Neurogenic Bladder

Intervention: tamsolusin (Drug); prazosin (Drug)

Phase: Phase 1/Phase 2

Status: Active, not recruiting

Sponsored by: Tabriz University

Official(s) and/or principal investigator(s):
SAKINEH hajebrahimi, MD, Study Director, Affiliation: Urology department ofTabriz University of Medical Sciences

Summary

The purpose of this study is to determine whether Tamsolusin or Prazosin are effective in the treatment of female voiding dysfunction(BOO)

Clinical Details

Official title: Effect of Tamsulosin vs Prazosin in Treatment of Female Voiding Dysfunction

Study design: Treatment, Randomized, Double Blind (Subject, Outcomes Assessor), Active Control, Parallel Assignment, Safety/Efficacy Study

Primary outcome: patient symptoms improvement(Standard questionare)

Secondary outcome: Urodynamics parameters improvement

Detailed description: Voiding dysfunction is not uncommon in Tabriz. About 20% of patients in female urology clinic of Tabriz university of medical sciences sufered from some degrees of voiding dysfunction (due to bladder imparement or bladder outlet obstruction).There is limited information about medical treatment of those patients. On the other hand alpha adrenergic blockers are the first choice medication in BENIGN PROSTATIC HYPERPLASIA. There is some new facts about destribution of alpha adrenergic blockers in female pelvic floor. The purpose of this study is to comparision whether Tamsolusin 0. 4/daily or Prazosin 1 mg/daily are effective in the treatment of female voiding dysfunction(BOO)

Eligibility

Minimum age: 20 Years. Maximum age: 70 Years. Gender(s): Female.

Criteria:

Inclusion Criteria:

- Healthy females with voiding difficulty with MFR<12 and post void residual urine>50cc

Exclusion Criteria:

- History of pelvic floor surgury during last 3 month

- Any contraindication for Tamsolusin or prazosin

Locations and Contacts

Additional Information

Starting date: July 2005
Ending date: March 2008
Last updated: January 26, 2008

Page last updated: June 20, 2008

-- advertisement -- The American Red Cross
We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2009